I personally think getting any results from any of the phase 3 COVID trials before the end of the year is quite fanciful. Not Team Dimerix's fault. If anything it goes to show how well Team Dimerix did last year to deliver 2x Phase 2 trials on time and budget last year during the COVID madness whilst others are having delays and blowouts. I'm still backing Nina and management
DXB Chart, page-109
Add DXB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
45.0¢ |
Change
0.040(9.76%) |
Mkt cap ! $253.4M | |||
| Open | High | Low | Value | Volume |
| 41.5¢ | 46.5¢ | 41.0¢ | $3.096M | 6.951M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 136030 | 44.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 45.0¢ | 115097 | 5 |
View Market Depth
| Last trade - 15.19pm 10/10/2024 (20 minute delay) ? |
| DXB (ASX) Chart |